OBJECTIVE To know about the perception and current status of drug risk management among pharmacists in Chinese medical institutions， providing insights and recommendations for enhancing the drug risk management system in medical institutions. METHODS A questionnaire survey was conducted across 28 provinces， cities， and autonomous regions； stratified radom sampling was employed to study the population of medical workers and pharmaceutical professionals in medical institutions nationwide. The survey included information on the survey population， the current status of drug risk management implementation in medical institutions， the cognition， definition and process of drug risk management related concepts， and the content and mode of drug risk management work in medical institutions. Finally， suggestions were collected from various medical institutions on the system construction of drug risk management. Descriptive statistical analysis was adopted to summarize the obtained data. RESULTS A total of 446 questionnaires were collected in this survey， including 420 valid questionnaires and 26 invalid questionnaires. The questionnaire collection rate was 100%，and the effective rate was 94.17%. 51.19% of the respondents No.2020YFC2009001）。 based their understanding of drug risk management on Management Measures for Adverse Drug Reaction Reports and Monitoring， while 87.38% recognized the need for drug risk management throughout the drug use process. 63.33% of the participants stated that their medical institutions had dedicated positions related to drug risk management， with the highest proportion （72.17%） was in third-grade class A medical institutions. 66.43% reported implementing risk management across all drug use stages. Suggestions for the development of drug risk management systems in medical institutions by the research participants focused on enhancing guiding documents， clarifying concepts， establishing information-sharing mechanisms. CONCLUSIONS The overall awareness of drug risk management in China’s medical institutions is high， with practices in place across various stages in multiple forms. However， there remains a need to strengthen institutional documents， management regulations， system development， and information-sharing mechanisms to improve collaborative governance， improve drug management levels， and ensure patient safety.

OBJECTIVE To investigate the improvement effects and mechanism of Xiangsha yiwei tang on gastric mucosal injury in rats with chronic atrophic gastritis （CAG）. METHODS Rats were randomly assigned into normal control group， model group， Xiangsha yiwei tang low-， medium- and high-dose groups （6， 12， 18 g/kg， calculated by crude drug）， and high-dose group of Xiangsha yiwei tang+740 Y-P [Xiangsha yiwei tang 18 g/kg+transforming growth factor β1/phosphatidyl inositol 3 kinase/ protein kinase B（TGF-β1/PI3K/Akt） pathway activator group 740 Y-P 10 mg/kg]， with 18 rats in each group. Rats in each group were administered the corresponding drugs via oral gavage or injection， once daily， for 4 consecutive weeks. Gastric mucosal blood flow， the levels of serum gastrointestinal hormones [including motilin （MTL）， gastrin （GAS）， and pepsinogen （PP）]， as well as inflammatory cytokines [including tumor necrosis factor- α （TNF- α）， interleukin-1β （IL-1β）， IL-6] in rats were measured. Pathological damage to gastric mucosal tissue was observed in rats； the apoptotic rate of gastric mucosal cells was detected. The expressions of TGF-β1/PI3K/Akt signaling pathway-related proteins and apoptosis-related proteins [including B-cell lymphoma-2 （Bcl-2） and Bcl-2-associated X protein （Bax）] in the gastric mucosal tissues of rats were assessed. RESULTS Compared with normal control group， model group had abnormal gastric mucosal tissue structure， with shedding of gastric mucosal epithelial cells， and prominent infiltration of inflammatory cells. Gastric mucosal blood flow， the serum levels of MTL， GAS， PP， and Bcl-2 protein expression were lowered significantly， while serum levels of TNF-α， IL-1β and IL-6， apoptosis rate， protein expressions of Bax and TGF-β1， the phosphorylations of PI3K and Akt were increased significantly （P＜0.05）. Compared with model group， Xiangsha yiwei decoction groups exhibited attenuated histopathological injuries in gastric mucosal tissues， reduced inflammatory cell infiltration， and significant improvements in the aforementioned quantitative parameters （P＜0.05）. Compared with high-dose group of Xiangsha yiwei tang， high-dose group of Xiangsha yiwei decoction combined with 740 Y-P exhibited significantly aggravated histopathological injuries in gastric mucosal tissues， and the aforementioned quantitative parameters were markedly reversed （P＜0.05）. CONCLUSIONS Xiangsha yiwei tang can alleviate gastric mucosal damage in CAG rats， and its mechanism of action is related to the inhibition of TGF-β1/PI3K/Akt signaling pathway.

The mitochondrial unfolded protein response(UPRmt)represents a crucial intracellular stress response mechanism that plays a fundamental role in maintaining mitochondrial and cellular homeostasis. Growing evidence suggests that dysregulation of UPRmt contributes significantly to the pathogenesis of various systemic disorders, including neurodegenerative diseases such as Parkinson's and Alzheimer's diseases, as well as age-related pathologies. Emerging research has particularly highlighted the involvement of UPRmt in ocular diseases, including cataracts, glaucoma, and diabetic retinopathy. This comprehensive review examines the physiological functions of UPRmt and its regulatory mechanisms in age-related eye diseases. The roles of key UPRmt downstream effector molecules in ocular cell populations such as lens epithelial cells, retinal pigment epithelial cells, and retinal ganglion cells are systematically analyzed. Importantly, the dual regulatory nature of UPRmt in ocular pathophysiology is discussed, that is, its moderate activation promotes mitochondrial homeostasis, mitigates oxidative stress, and suppresses inflammatory responses, its chronic or excessive activation triggers apoptotic pathways, induces metabolic dysfunction, and ultimately accelerates disease progression. By elucidating these mechanisms, our review provides novel insights into ocular disease pathogenesis and proposes potential therapeutic strategies targeting UPRmt modulation for the prevention and treatment of age-related eye disorders.

Non-small cell lung cancer （NSCLC）， as the most common subtype of lung cancer， has a high incidence and mortality rate among global cancer cases. Although modern medicine has made remarkable progress in the treatment of NSCLC with advances in screening technologies and continuous optimization of therapeutic regimens， current treatments inevitably result in adverse outcomes such as high tumor recurrence rates， significant toxic side effects， and poor quality of life for patients. Traditional Chinese medicine （TCM） holds that the core pathogenesis of lung cancer lies in ''deficiency of healthy Qi and excess of pathogenic factors''. It originates from congenital insufficiency or acquired malnourishment， leading to an imbalance of Yin and Yang， deficiency of healthy Qi， and inability to eliminate pathogenic factors. The interactions among Qi stagnation， phlegm accumulation， blood stasis， and toxins give rise to disease. The root is deficiency， while the manifestation is excess. Therefore， the treatment of lung cancer in TCM is generally guided by the principle of "supporting the healthy Qi and eliminating the pathogens". A large number of clinical and pharmacological studies have shown that TCM and its active components can， through multiple targets and mechanisms， alleviate postoperative and chemoradiotherapy-related adverse reactions， inhibit tumor growth and recurrence， and improve the quality of life of patients with NSCLC. It is worth noting that although extensive studies have been conducted on the therapeutic patterns and pharmacological mechanisms of TCM and its active substances in NSCLC treatment， issues such as the diversity of medicinal materials， the complexity of chemical components， the scientific basis of herbal compatibility， and the flexibility of dosage indicate that there is still considerable room for further clinical and basic research. This review summarizes recent literature on the clinical syndromes， drug selection， medication patterns， and pharmacological mechanisms of TCM and its active components in the treatment of NSCLC， aiming to provide guidance for clinical medication in TCM therapy for NSCLC and to deepen the understanding and research of its therapeutic mechanisms.

Peptide receptor radionuclide therapy (PRRT) with radiolabeled SSTR2 agonists is a treatment option that is highly effective in controlling metastatic and progressive neuroendocrine tumors (NETs). Previous studies have shown that an SSTR2 agonist combined with albumin binding moiety Evans blue (denoted as ¹⁷⁷Lu-EB-TATE) is characterized by a higher tumor uptake and residence time in preclinical models and in patients with metastatic NETs. This study aimed to enhance the in vivo stability, pharmacokinetics, and pharmacodynamics of ¹⁷⁷Lu-EB-TATE by replacing the maleimide-thiol group with a polyethylene glycol chain, resulting in a novel EB conjugated SSTR2-targeting radiopharmaceutical, ¹⁷⁷Lu-LNC1010, for PRRT. In preclinical studies, ¹⁷⁷Lu-LNC1010 exhibited good stability and SSTR2-binding affinity in AR42J tumor cells and enhanced uptake and prolonged retention in AR42J tumor xenografts. Thereafter, we presented the first-in-human dose escalation study of ¹⁷⁷Lu-LNC1010 in patients with advanced/metastatic NETs. ¹⁷⁷Lu-LNC1010 was well-tolerated by all patients, with minor adverse effects, and exhibited significant uptake and prolonged retention in tumor lesions, with higher tumor radiation doses than those of ¹⁷⁷Lu-EB-TATE. Preliminary PRRT efficacy results showed an 83% disease control rate and a 42% overall response rate after two ¹⁷⁷Lu-LNC1010 treatment cycles. These encouraging findings warrant further investigations through multicenter, prospective, and randomized controlled trials.

Objective:To investigate the auditory and speech abilities of children with congenital auditory neuropathy (AN) after cochlear implant (CI), and to analyze the role of genetic testing in predicting the postoperative outcomes of CI in AN patients.Methods:Fourteen children diagnosed with AN by audiological battery test and underwent CI surgery in Xijing Hospital of the Air Force Medical University from 2002 to 2021 were included in this study (9 males and 5 females), with an implantation age of (3.1±1.7) years (mean±standard deviation, the same as follows). The preoperative audiological results and deafness gene results were analyzed. Another 52 children with ordinary sensorineural hearing loss (SNHL) were selected as the control group (30 males and 22 females), with an implantation age of (2.2±0.9) years. The demographic factors such as age and gender were matched with those of the AN group. The modified Category Auditory Performance (CAP-Ⅱ) and Speech Intelligence Rate (SIR) were used to evaluate the development of postoperative auditory and speech abilities in two groups. The Mandarin Speech Test System was used to test the speech recognition rate of monosyllabic and disyllabic words and sentences. Matlab 2022 software was used to analyze the data.Results:The results of gene in 14 children with AN showed that 6 cases had OTOF gene mutations, 2 cases (siblings) were confirmed to have TNN gene mutations through whole exome sequencing, and the remaining 6 cases were not find any clear pathogenic gene mutations. All subjects underwent CI surgery with electrodes implanted into the cochlea smoothly, and there were no postoperative complications. After surgery, all AN children had improved auditory and speech abilities, but only 64% (9/14) of AN children with CI had auditory ability scores comparable to the control group of SNHL children (including 2 children with TNN gene mutations), and 36% (5/14) of AN children had lower scores than the control group of SNHL children.The average speech recognition rate of two children with TNN gene mutations was 86.5%, and of two children with OTOF gene mutations was 83.2%. Conclusions:AN children achieved varying degrees of auditory and speech abilities after CI, but the postoperative effects varied greatly. Some children achieved similar results as ordinary SNHL children, but there were still some children whose effects were worse than those of ordinary SNHL children. The postoperative efficacy of CI in two children with AN caused by TNN pathogenic genes were comparable to that of ordinary SNHL in children. Genetic testing had certain reference value for predicting the postoperative effect of CI in AN children.

Objective:To systematically review the non-surgical and minimally invasive treatment techniques for diabetic foot ulcers, in order to provide evidence-based medical reference for orthopedic surgeons in the treatment of diabetic foot ulcers.Methods:Chinese and English databases such as PubMed, Embase, the Cochrane Library, CNKI, Wanfang and VIP were used to search the literature related to non-surgical and minimally invasive treatment of diabetic foot ulcers. The retrieval time was set to September 2023. The key words were Diabetic Foot Ulcer, Minimally Invasive Surgical Treatment, Non-surgical Treatment. According to the research type of the included literature, the quality of the included literature was evaluated by selecting corresponding tools. The outcome measures mainly included treatment response rate, amputation rate, mortality rate and other measures related to treatment effect. The Medical Literature King software was used to screen literatures and extract relevant data for systematic review.Results:In this study, 20 articles were included. There were 15 studies from China, 2 studies from Egypt, 2 study from the United States, and 1 study from Sweden. There were 16 high quality literatures and 4 low quality literatures. Among them, there were five non-surgical treatment techniques of diabetic foot ulcers, including customized diabetic foot insoles, autologous platelet-rich plasma (PRP) , Chinese medicine treatment, external dressing therapy, and vacuum sealing drainage (VSD) technology. There were two minimally invasive treatment techniques for diabetic foot ulcer, including vascular intervention technology and periosteal distraction technology. The plastic surgeon should choose the appropriate treatment technique according to the specific situation of the patient with DFUs. Diabetes custom insoles were mainly used in the treatment of patients with recurrent DFUs or Wagner grade 0. For DFUs patients with Wagner grade 1 and above, the effect of PRP, VSD and vascular intervention techniques were more significant. Traditional Chinese medicine also showed significant result in the treatment of DFUs patients with Wagner grade 1 and above. Topical dressing treatment was often used for daily dressing change of DFUs to promote wound healing. Periosteal distraction technique was less invasive and had significant therapeutic effect on severe DFUs.Conclusions:Non-surgical and minimally invasive techniques are effective in the treatment of DFUs. Plastic surgeons should master and reasonably choose these non-surgical and minimally invasive treatment techniques for the treatment of patients with DFUs according to the patients＇conditions and medical conditions.

Objective:To systematically review the non-surgical and minimally invasive treatment techniques for diabetic foot ulcers(DFUs), in order to provide evidence-based medical reference for orthopedic surgeons in the treatment of diabetic foot ulcers.Methods:Chinese and English databases such as PubMed, Embase, The Cochrane Library, CNKI, Wanfang and VIP were utilized to search the literature related to non-surgical and minimally invasive treatment of diabetic foot ulcers. The retrieval time was set to September 2023. The key words were Diabetic Foot Ulcer, Minimally Invasive Surgical Treatment, Non-surgical Treatment. According to the research type of the included literature, the quality of the included literature was evaluated by selecting corresponding tools. The outcome measures mainly included treatment response rate, amputation rate, mortality rate and other measures related to treatment effect. The Medical Literature King software was used to screen literatures and extract relevant data for systematic review.Results:In this study, 20 articles were included. There were 15 studies from China, 2 studies from Egypt, 2 studies from the United States, and 1 study from Sweden. There were 16 high quality literatures and 4 low quality literatures. Among them, there were five non-surgical treatment techniques of diabetic foot ulcers, including customized diabetic foot insoles, autologous platelet-rich plasma (PRP), Chinese medicine treatment, external dressing therapy, and vacuum sealing drainage (VSD) technology. There were two minimally invasive treatment techniques for diabetic foot ulcer, including vascular intervention technology and periosteal distraction technology. The plastic surgeon should choose the appropriate treatment technique according to the specific situation of the patient with DFUs. Diabetes custom insoles were mainly used in the treatment of patients with recurrent DFUs or Wagner grade 0. For DFUs patients with Wagner grade 1 and above, the effect of PRP, VSD and vascular intervention techniques were more significant. Traditional Chinese medicine also showed significant result in the treatment of DFUs patients with Wagner grade 1 and above. Topical dressing treatment was often used for daily dressing change of DFUs to promote wound healing. Periosteal distraction technique was less invasive and had significant therapeutic effect on severe DFUs.Conclusion:Non-surgical and minimally invasive techniques are effective in the treatment of DFUs. Plastic surgeons should master and reasonably choose these non-surgical and minimally invasive treatment techniques for the treatment of patients with DFUs based on the patients’ conditions and medical conditions.

Objective:To systematically review the non-surgical and minimally invasive treatment techniques for diabetic foot ulcers, in order to provide evidence-based medical reference for orthopedic surgeons in the treatment of diabetic foot ulcers.Methods:Chinese and English databases such as PubMed, Embase, the Cochrane Library, CNKI, Wanfang and VIP were used to search the literature related to non-surgical and minimally invasive treatment of diabetic foot ulcers. The retrieval time was set to September 2023. The key words were Diabetic Foot Ulcer, Minimally Invasive Surgical Treatment, Non-surgical Treatment. According to the research type of the included literature, the quality of the included literature was evaluated by selecting corresponding tools. The outcome measures mainly included treatment response rate, amputation rate, mortality rate and other measures related to treatment effect. The Medical Literature King software was used to screen literatures and extract relevant data for systematic review.Results:In this study, 20 articles were included. There were 15 studies from China, 2 studies from Egypt, 2 study from the United States, and 1 study from Sweden. There were 16 high quality literatures and 4 low quality literatures. Among them, there were five non-surgical treatment techniques of diabetic foot ulcers, including customized diabetic foot insoles, autologous platelet-rich plasma (PRP) , Chinese medicine treatment, external dressing therapy, and vacuum sealing drainage (VSD) technology. There were two minimally invasive treatment techniques for diabetic foot ulcer, including vascular intervention technology and periosteal distraction technology. The plastic surgeon should choose the appropriate treatment technique according to the specific situation of the patient with DFUs. Diabetes custom insoles were mainly used in the treatment of patients with recurrent DFUs or Wagner grade 0. For DFUs patients with Wagner grade 1 and above, the effect of PRP, VSD and vascular intervention techniques were more significant. Traditional Chinese medicine also showed significant result in the treatment of DFUs patients with Wagner grade 1 and above. Topical dressing treatment was often used for daily dressing change of DFUs to promote wound healing. Periosteal distraction technique was less invasive and had significant therapeutic effect on severe DFUs.Conclusions:Non-surgical and minimally invasive techniques are effective in the treatment of DFUs. Plastic surgeons should master and reasonably choose these non-surgical and minimally invasive treatment techniques for the treatment of patients with DFUs according to the patients＇conditions and medical conditions.

Objective:To systematically review the non-surgical and minimally invasive treatment techniques for diabetic foot ulcers(DFUs), in order to provide evidence-based medical reference for orthopedic surgeons in the treatment of diabetic foot ulcers.Methods:Chinese and English databases such as PubMed, Embase, The Cochrane Library, CNKI, Wanfang and VIP were utilized to search the literature related to non-surgical and minimally invasive treatment of diabetic foot ulcers. The retrieval time was set to September 2023. The key words were Diabetic Foot Ulcer, Minimally Invasive Surgical Treatment, Non-surgical Treatment. According to the research type of the included literature, the quality of the included literature was evaluated by selecting corresponding tools. The outcome measures mainly included treatment response rate, amputation rate, mortality rate and other measures related to treatment effect. The Medical Literature King software was used to screen literatures and extract relevant data for systematic review.Results:In this study, 20 articles were included. There were 15 studies from China, 2 studies from Egypt, 2 studies from the United States, and 1 study from Sweden. There were 16 high quality literatures and 4 low quality literatures. Among them, there were five non-surgical treatment techniques of diabetic foot ulcers, including customized diabetic foot insoles, autologous platelet-rich plasma (PRP), Chinese medicine treatment, external dressing therapy, and vacuum sealing drainage (VSD) technology. There were two minimally invasive treatment techniques for diabetic foot ulcer, including vascular intervention technology and periosteal distraction technology. The plastic surgeon should choose the appropriate treatment technique according to the specific situation of the patient with DFUs. Diabetes custom insoles were mainly used in the treatment of patients with recurrent DFUs or Wagner grade 0. For DFUs patients with Wagner grade 1 and above, the effect of PRP, VSD and vascular intervention techniques were more significant. Traditional Chinese medicine also showed significant result in the treatment of DFUs patients with Wagner grade 1 and above. Topical dressing treatment was often used for daily dressing change of DFUs to promote wound healing. Periosteal distraction technique was less invasive and had significant therapeutic effect on severe DFUs.Conclusion:Non-surgical and minimally invasive techniques are effective in the treatment of DFUs. Plastic surgeons should master and reasonably choose these non-surgical and minimally invasive treatment techniques for the treatment of patients with DFUs based on the patients’ conditions and medical conditions.